TY - CHAP AU - Nikolaos Kanellias AU - Maria Gavriatopoulou AU - Evangelos Terpos ED - Ota Fuchs Y1 - 2021-07-07 PY - 2021 T1 - Antibody Therapies for Multiple Myeloma N2 - This book deals with the diagnosis and treatment of multiple myeloma. Multiple myeloma is a plasma cell disorder, the prognosis of which has dramatically improved in the last years thanks to new immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, in relapsed/refractory disease and a diagnosis. Chapters cover such topics as prognostic and predictive factors in newly diagnosed multiple myeloma, treatment approaches, antibody therapies, and three-dimensional (3D) models mimicking multiple myeloma bone marrow–microenvironment interactions. BT - Multiple Myeloma SP - Ch. 4 UR - https://doi.org/10.5772/intechopen.98656 DO - 10.5772/intechopen.98656 SN - 978-1-83968-621-4 PB - IntechOpen CY - Rijeka Y2 - 2024-03-28 ER -